You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 89 No. 4, October 1964 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (11)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Management of Experimental Endotoxin Shock

The Circulatory Effects of Levarterenol, Hydrocortisone, Phenoxybenzamine Hydrochloride, and Blood Volume Expansion

LOUIS L. SMITH, MD; WALTER MULLER, MD; DAVID B. HINSHAW, MD

AMA Arch Surg. 1964;89(4):630-636.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Shock associated with infection is a serious cardiovascular complication associated with a high mortality. Many facets of this complex circulatory disturbance remain obscure; however, the clinical features are quite characteristic. Bacterial shock is often observed in patients with Gram-negative infections. Cardiovascular collapse usually follows the abrupt onset of hyperpyrexia and chills, suggesting the entrance of bacteria or bacterial products into the blood stream. Despite intensive treatment, the mortality rate in this type of shock is uniformly high.

Current therapy has been directed toward the control of the initiating infection. Supportive measures have included the use of vasopressors, pharmacological doses of corticosteroids,* and plasma volume replacement. Vasodilator drugs have been suggested since they have been successful in lowering mortality in pretreated animals subjected to endotoxic shock.

Despite the widespread use of the therapeutic agents listed above, little specific data is available regarding their effect on circulatory dynamics in the management of . . . [Full Text PDF of this Article]


Author Affiliations

LOS ANGELES

Associate Professor of Surgery, Director of the Surgical Research Laboratory (Dr. Smith); Surgical Research Fellow (Dr. Muller); and Professor and Chairman, Department of Surgery (Dr. Hinshaw), Loma Linda University.; From the Department of Surgery and Surgical Research Laboratory, Loma Linda University School of Medicine.


Footnotes

Submitted for publication April 10, 1964.

Supported by United States Public Health Service grant No. HE 4639, National Heart Institute.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1964 American Medical Association. All Rights Reserved.